Comorbid conditions in patients with hypertension on the background of occupational hazards create additional problems in the treatment of hypertension. An analysis of working conditions in 76 workers of the Ivano-Frankivsk armature factory who underwent regular medical check-ups regarding first-/second-degree hypertension (the main group) showed that they were exposed to occupational hazards of chemical (acrolein carbon, iron oxide, chromium, fluorine compounds, sulfuric acid) and physical (high temperature, noise, vibration, electromagnetic radiation, dust) nature for a long period of time (from 4 to 11 years). Comorbid conditions were most often observed among the patients of the main group as compared to the patients of the control group (n = 17), who were not exposed to occupational hazards - 82.06% and 73.34% of cases, respectively. In the patients of the main group, chronic bronchitis was detected in 26.56% of cases and coronary artery disease was diagnosed in 25.09% of cases as compared to 8.33% and 18.34% of cases in the control group. At the same time, 38.89% of hypertensive patients of the main group were diagnosed with chronic bronchitis and concomitant coronary artery disease, which were not observed in the patients of the control group. The patients of the main group were more likely to have dyslipidemia, left ventricular hypertrophy, aortic fibrosis, hypertensive retinopathy as compared to the patients of the control group. In the control group, patients with overweight and type 2 diabetes mellitus prevailed. Quality of life assessment using the 36-Item Short Form Health Survey among the patients of the main group revealed a significant decrease in the indicators of physical and vital activity, fulfillment of daily professional duties. In the control group, a worsening emotional state prevailed.
Babanov SA, Baraeva RA, Budash DS. Lesions of cardiovascular system in the practice of a pathologist. World of Transport and Transportation. 2016; 14 (4): 106-111. DOI: https://doi.org/10.21145/2499-9954-2016-4-106-111
Basanets AV, Andruschenko TA. Cardiovascular diseases under the action of occupational factors. Ukrainian Journal of Occupational Health. 2010; 22: 71-81. DOI: https://doi.org/10.33573/ujoh2010.02.071
Belyaev OV, Kuznetsova ZM. Kompleksnyy analiz faktorov riska arterialnoy gipertoniyi u lits, zanyatykh upravlencheskim trudom. Kardiologiya. 2006; 4: 20-23.
Vertkin AL, Skotnikov AS, Tikhonovskaya EYu et al. Komorbidnost pri KHOBL: rol khronicheskogo sistemnogo vospaleniya. RMZH " Meditsinskoye obozreniye". 2014; 11: 8-11.
Dauletbakova DN. Izucheniye kachestva zhizni bolnykh arterialnoy gipertenziyey na osnovaniyi ispolzovaniya oprosnika SF-36. Molodoy uchenyy. 2018; 23 (209): 23-28.
Zerbino DD, Solomenchuk TM. Development of Acute Coronary Pathology in Young Patients: Environmental Concept and Epidemiological Arguments in its Support. Medicine of Ukraine. 2010; 10 (1): 49-56.
Lopatin YuM, Ilyukhin OV. Kontrol zhestkosti sosudov. Klinicheskoye znacheniye i sposoby korrektsiyi. Serdtse. 2007; 3 (35): 128-132.
Nesen AO. Khronichni neinfektsiini zakhvoriuvannia: aktsent na komorbidnist i pidvyshchenyi kardiovaskuliarnyi ryzyk. Ukrainian Therapeutical Journal. 2014; 2: 26-32.
Oganov RG, Simanenkov IV, Bakulin IG et al. Comorbidities in clinical practice. Algorithms for diagnostics and treatment. Cardiovascular Therapy and Prevention. 2019; 18 (1): 5-66. DOI: https://doi.org/10.15829/1728-8800-2019-1-5-66
Ostroumova OD, Kochetkov AI, Guseva TF. Blood pressure variability in hypertension associated with coronary heart disease: prognostic value and management approaches. Arterial Hypertension. 2018; 24 (2): 246-256. DOI: https://doi.org/10.18705/1607-419X-2018-24-2-246-256
Rekomendatsii Ukrainskoii asotsiatsii kardiolohiv z profilaktyky ta likuvannia arterialnoi hipertenzii. Kyiv; c2011. 84p.
Shamukhamedova NSh, Agzamova UA. Arterial hypertension and chronic obstructive pulmonary disease - problems of choice of therapy. Colloquium-journal. 2019; 2 (26): 15-17.
Schirpenbach C, Reincke M. Epidemiology and etiology of therapy-resistant hypertension. Internist (Berl). 2009; 50 (1): 7-16. DOI: https://doi.org/10.1007/s00108-008-2194-9 [PMid:19043688]
Whelton PK et al. 2017 High Blood Pressure Clinical Practice Guideline: Executive Summary. c2017. 401p.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.